P&K Skin Research Center Co Ltd
KOSDAQ:347740
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P&K Skin Research Center Co Ltd
Total Equity
P&K Skin Research Center Co Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
P&K Skin Research Center Co Ltd
KOSDAQ:347740
|
Total Equity
₩76.9B
|
CAGR 3-Years
7%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
Samsung Biologics Co Ltd
KRX:207940
|
Total Equity
₩12.2T
|
CAGR 3-Years
11%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
A
|
ADM Korea Inc
KOSDAQ:187660
|
Total Equity
₩21.5B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Total Equity
₩146.3B
|
CAGR 3-Years
40%
|
CAGR 5-Years
14%
|
CAGR 10-Years
24%
|
|
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Total Equity
₩593.4B
|
CAGR 3-Years
21%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Total Equity
₩507.6B
|
CAGR 3-Years
32%
|
CAGR 5-Years
35%
|
CAGR 10-Years
28%
|
|
P&K Skin Research Center Co Ltd
Glance View
P&K Skin Research Center Co. Ltd. engages in the examination and assessment of cosmetics and skincare products. The company is headquartered in Seoul, Seoul. The company went IPO on 2020-09-09. The firm provides services such as human application testing, safety tests, cosmetic efficacy tests, cosmeceuticals tests, health food tests, sensory tests, and in vitro tests. In addition, the Company perform scientific evaluations of efficacy for products applied to human skin to provide information about the products and technical support.
See Also
What is P&K Skin Research Center Co Ltd's Total Equity?
Total Equity
76.9B
KRW
Based on the financial report for Dec 31, 2024, P&K Skin Research Center Co Ltd's Total Equity amounts to 76.9B KRW.
What is P&K Skin Research Center Co Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
26%
Over the last year, the Total Equity growth was 4%. The average annual Total Equity growth rates for P&K Skin Research Center Co Ltd have been 7% over the past three years , 26% over the past five years .
